Literature DB >> 12376714

Pyothorax-associated large B-cell lymphoma: case report with emphasis on the potential diagnostic challenge.

P C W Lui1, W K Ng, L Y C Yam, W W C Wong, Y P Tai.   

Abstract

A rare case of pyothorax-associated large B-cell lymphoma occurring in Hong Kong is reported. The patient was a 64-year-old Chinese male who presented with shortness of breath and pleuritic pain. Radiological examination revealed left pleural thickening associated with bilateral pleural effusion. Open biopsy of the thickened parietal pleura revealed occasional large malignant lymphoid cells of B lineage admixed with fibrin and hyalinised fibrous tissue. These lymphoma cells were shown to harbour both Epstein-Barr virus and human herpesvirus type 8 by in situ hybridisation and immunohistochemical study, respectively. There was no associated lymphadenopathy and hepatosplenomegaly. The clinicoradiological presentation and pathological findings thus fulfilled the criteria of the so-called pyothorax-associated large B-cell lymphoma. Awareness of this rare entity, together with diligent histological examination and proper application of ancillary investigative techniques, are essential for making a correct diagnosis. The co-infection with Epstein-Barr virus and human herpesvirus type 8 in this case also suggests a possible pathogenetic relationship between pyothorax-associated large B-cell lymphoma and primary effusion lymphoma.

Entities:  

Mesh:

Year:  2002        PMID: 12376714

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  2 in total

1.  Pyothorax-associated lymphoma (PAL): report and review of a rare entity.

Authors:  Katrin Welcker; Masaki Nakashima; Klaus-Dieter Diemel; Lutz Welker; Jürgen Galle; Hartmut Merz; Detlev Branscheid
Journal:  Thorac Surg Sci       Date:  2004-10-01

2.  Primary Pleural Diffuse Large B-cell non-Hodgkin's Lymphoma Diagnosed via [18F]-2-Fluoro-Deoxy-DGlucose Positron Emission Tomography /Computed Tomography.

Authors:  Ilknur Ak Sivrikoz; Zafer Gülbaş
Journal:  Turk J Haematol       Date:  2012-03-05       Impact factor: 1.831

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.